117 results
Page 4 of 6
8-K
EX-99.1
skbdek60jm 6zwrrnwam
5 Aug 21
Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights
8:02am
8-K
EX-10.1
j78 d44c2y7o5
1 Jun 21
Entry into a Material Definitive Agreement
9:02am
424B5
n4ity aktcdguh9
1 Jun 21
Prospectus supplement for primary offering
9:01am
8-K
EX-99.1
yimd yiv8jhu96guyqj
17 May 21
Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management
4:10pm
8-K
EX-99.1
hbdvto6dt5b6
5 May 21
Baudax Bio Reports First Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
gs9b1 u7pbgv
26 Apr 21
Other Events
4:06pm
8-K
EX-10.1
s56hz5nkuiibuw
11 Mar 21
Departure of Directors or Certain Officers
4:42pm
PRE 14A
p0ye0wedrr92qy qxt
1 Mar 21
Preliminary proxy
5:29pm
8-K
EX-99.1
jn54 lafzh0u1m6ygg
16 Feb 21
Baudax Bio Reports 2020 Annual Financial Results
7:44am
8-K
EX-10.1
w0fw4elijqjy4zmv
9 Feb 21
Entry into a Material Definitive Agreement
5:11pm
424B5
fi8 kzmi9be
9 Feb 21
Prospectus supplement for primary offering
5:10pm
424B5
nwxu4n5ei lpi9e9
22 Jan 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
8d93ip7d0g6jm
5 Jan 21
Other Events
8:05am
8-K
EX-10.1
7lira dqb7tit5
18 Dec 20
Entry into a Material Definitive Agreement
7:00am
424B5
yapp x7q2yz4
17 Dec 20
Prospectus supplement for primary offering
9:54pm